Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paeoniflorin and Photodynamic Therapy for Oral Lichen Planus
NCT05973097Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of total glucosides of paeony in oral lichen planus (OLP) (3 arms), sponsored by Peking University Third Hospital. Primary endpoint: Efficacy at 1 month of treatment. Started Jul 2023; status: recruiting.
02
Drugs
total glucosides of paeony
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT05973097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973097.